Literature DB >> 12668451

Mechanical defects of muscle fibers with myosin light chain mutants that cause cardiomyopathy.

Osha Roopnarine1.   

Abstract

Familial hypertrophic cardiomyopathy is a disease caused by single mutations in several sarcomeric proteins, including the human myosin ventricular regulatory light chain (vRLC). The effects of four of these mutations (A13T, F18L, E22K, and P95A) in vRLC on force generation were determined as a function of Ca(2+) concentration. The endogenous RLC was removed from skinned rabbit psoas muscle fibers, and replaced with either rat wildtype vRLC or recombinant rat vRLC (G13T, F18L, E22K, and P95A). Compared to fibers with wildtype rat vRLC, the E22K mutant increased Ca sensitivity of force generation, whereas the G13T and F18L mutants decreased the Ca sensitivity, and the P95A mutant had no significant effect. None of the RLC mutants affected the maximal tension (observed at saturating Ca(2+) concentrations), except for F18L, which decreased the maximal tension to 69 +/- 10% of the wildtype value. Of the mutant RLCs, only F18L decreased the cooperativity of activation of force generation. These results suggest that the primary cause of familial hypertrophic cardiomyopathy, in some cases, is perturbation in the Ca sensitivity of force generation, in which Ca-sensitizing or Ca-desensitizing effects can lead to similar disease phenotypes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668451      PMCID: PMC1302809          DOI: 10.1016/S0006-3495(03)75048-6

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  37 in total

Review 1.  The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms.

Authors:  J G Seidman; C Seidman
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Invited Review: pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation.

Authors:  O M Hernandez; P R Housmans; J D Potter
Journal:  J Appl Physiol (1985)       Date:  2001-03

3.  Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations.

Authors:  P S Andersen; O Havndrup; H Bundgaard; J C Moolman-Smook; L A Larsen; J Mogensen; P A Brink; A D Børglum; V A Corfield; K Kjeldsen; J Vuust; M Christiansen
Journal:  J Med Genet       Date:  2001-12       Impact factor: 6.318

Review 4.  Familial hypertrophic cardiomyopathic myosin mutations that affect the actin-myosin interaction.

Authors:  Osha Roopnarine
Journal:  Results Probl Cell Differ       Date:  2002

Review 5.  Changes in actin and myosin structural dynamics due to their weak and strong interactions.

Authors:  David D Thomas; Ewa Prochniewicz; Osha Roopnarine
Journal:  Results Probl Cell Differ       Date:  2002

Review 6.  Skeletal and cardiac muscle contractile activation: tropomyosin "rocks and rolls".

Authors:  A M Gordon; M Regnier; E Homsher
Journal:  News Physiol Sci       Date:  2001-04

7.  Influence of length on force and activation-dependent changes in troponin c structure in skinned cardiac and fast skeletal muscle.

Authors:  D A Martyn; A M Gordon
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

8.  Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation.

Authors:  D Szczesna; D Ghosh; Q Li; A V Gomes; G Guzman; C Arana; G Zhi; J T Stull; J D Potter
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

9.  Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2.

Authors:  A Sanbe; J G Fewell; J Gulick; H Osinska; J Lorenz; D G Hall; L A Murray; T R Kimball; S A Witt; J Robbins
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

10.  In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy.

Authors:  A Sanbe; D Nelson; J Gulick; E Setser; H Osinska; X Wang; T E Hewett; R Klevitsky; E Hayes; D M Warshaw; J Robbins
Journal:  Circ Res       Date:  2000-08-18       Impact factor: 17.367

View more
  7 in total

1.  Three distinct actin-attached structural states of myosin in muscle fibers.

Authors:  Ryan N Mello; David D Thomas
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

Review 2.  Molecular genetics and pathogenesis of cardiomyopathy.

Authors:  Akinori Kimura
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

Review 3.  Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.

Authors:  Sunil Yadav; Yoel H Sitbon; Katarzyna Kazmierczak; Danuta Szczesna-Cordary
Journal:  Pflugers Arch       Date:  2019-01-31       Impact factor: 3.657

4.  Interplay of troponin- and Myosin-based pathways of calcium activation in skeletal and cardiac muscle: the use of W7 as an inhibitor of thin filament activation.

Authors:  Bishow B Adhikari; Kuan Wang
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

5.  Proteomic analysis of metabolic, cytoskeletal and stress response proteins in human heart failure.

Authors:  Weiming Li; Rong Rong; Sheng Zhao; Xiaoming Zhu; Ke Zhang; Xin Xiong; Xueqing Yu; Qinghua Cui; Shuqiang Li; Li Chen; Jun Cai; Jie Du
Journal:  J Cell Mol Med       Date:  2012-01       Impact factor: 5.310

6.  Myosin lever arm orientation in muscle determined with high angular resolution using bifunctional spin labels.

Authors:  Yahor Savich; Benjamin P Binder; Andrew R Thompson; David D Thomas
Journal:  J Gen Physiol       Date:  2019-06-21       Impact factor: 4.086

7.  Programmed Exercise Attenuates Familial Hypertrophic Cardiomyopathy in Transgenic E22K Mice via Inhibition of PKC-α/NFAT Pathway.

Authors:  Haiying Wang; Yuedong Lin; Ran Zhang; Yafen Chen; Wei Ji; Shenwei Li; Li Wang; Rubin Tan; Jinxiang Yuan
Journal:  Front Cardiovasc Med       Date:  2022-02-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.